'Lights, Camera, Action!' Movie Posters Help Kids Cope With Cancer in the Family

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 15 No 7
Volume 15
Issue 7

As part of the "Good Grief" support groups at the Ohio State University James Cancer Hospital, children coping with the illness or death of a loved one from cancer are the stars of their own movie posters, complete with the name of their fictional movie, story line, characters, and opening date (generally the child's birthday).

As part of the "Good Grief" support groups at the Ohio State University James Cancer Hospital, children coping with the illness or death of a loved one from cancer are the stars of their own movie posters, complete with the name of their fictional movie, story line, characters, and opening date (generally the child's birthday). "Story lines often revolve around hating the cancer and loving their families," said Pauline King, RN, director of children's programs. "These aren't things children would innately say, but through this process, they communicate their feelings." Younger children often dress up as superheroes, princesses, or fairies, while teenagers often portray themselves as action heroes. Some brandish lasers and swords, trying to kill the cancer. "This is an art form the children can really relate to, and the posters help them process their grief in a very personal way," Ms. King said.

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content